Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Circulation

• Publication date

  2004-12-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000150390.04704.B7PMID 15583079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).

  2004cited by this paper
• PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION

  2002cited by this paper
• Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

  2002cited by this paper
• Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

  2002cited by this paper
• Electrical Storm Presages Nonsudden Death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial

  2001cited by this paper
• Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

  2000cited by this paper
• A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

  1999cited by this paper
• Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators.

  1999cited by this paper
• Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure.

  1998cited by this paper
• A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

  1997cited by this paper
• Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.

  1997cited by this paper
• Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

  1996cited by this paper
• Clinical Classification of Cardiac Deaths

  1982cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Efficacy and safety of ventricular tachycardia ablation versus antiarrhythmics in ischemic cardiomyopathy: a network meta-analysis.

  2026cites this paper
• Predictors and Prognostic Significance of Appropriate Implantable Cardioverter-Defibrillator Therapy in Primary Prevention Patients with Ischemic Cardiomyopathy

  2026influential citation
• The Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Selection, Implantation, and Management of Patients With Cardiac Implantable Electronic Devices.

  2026cites this paper
• Muerte súbita: estratificación del riesgo por resonancia magnética cardíaca

  2025cites this paper
• Approach to Ventricular Arrhythmias in Heart Failure

  2025cites this paper
• Predictors of Atrial High‐Rate Episodes and Inappropriate Device Therapy in Implantable Cardioverter Defibrillators

  2025cites this paper
• Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: A Meta‐Analysis With Reconstructed Time‐to‐Event and Trial Sequential Analysis

  2025cites this paper
• Novel F-18-labeled Tracers of Sympathetic Function for Improved Risk Stratification and Clinical Outcomes

  2025cites this paper
• Sudden cardiac death: Risk stratification using cardiac MRI.

  2025cites this paper
• High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial

  2025cites this paper
• Non-Invasive Assessment of the Ventricular Arrhythmogenic Substrate Using Electrocardiographic Imaging During Sinus Rhythm: the NIAVAS study.

  2025cites this paper
• Unsupervised phenotypic clustering of cardiac MRI data reveals distinct subgroups associated with outcomes in ischemic cardiomyopathy

  2025cites this paper
• Early is on time: Minimizing implantable cardioverter-defibrillator shocks through expedited antitachycardia pacing

  2025cites this paper
• Artificial intelligence in arrhythmias and sudden cardiac arrest

  2025cites this paper
• Sudden cardiac arrest prediction via deep learning electrocardiogram analysis

  2025cites this paper
• Ten‐Year Outcomes and Predictors of Mortality Following Catheter Ablation of Ventricular Tachycardia

  2024cites this paper
• Assessing the impact of omega-3 fatty acids on ventricular tachyarrhythmia and survival in patients with ICDs: A systematic review and meta-analysis

  2024cites this paper
• Active Arrhythmia Pattern: A Novel Predictor of ICD Shocks—A Subanalysis From the PARTITA Study

  2024cites this paper
• Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.

  2024cites this paper
• RIPPLE-VT Study: Multicentre, prospective evaluation of ventricular tachycardia substrate ablation by targeting scar channels to eliminate latest scar potentials without direct ablation.

  2024cites this paper
• Catheter Ablation of Ventricular Tachycardia in Ischemic Heart Disease: What Is Known and New Perspectives

  2024cites this paper
• Incidence and risk factors for first and recurrent ICD shock therapy in patients with an implantable cardioverter defibrillator

  2024cites this paper
• Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion

  2024cites this paper
• A Systematic Review and Meta-Analysis of Catheter Ablation Versus Anti-arrhythmic Drugs for Treatment of Ventricular Arrhythmia

  2024cites this paper
• Comparison of Oral Procainamide and Mexiletine Treatment of Recurrent and Refractory Ventricular Tachyarrhythmias

  2024cites this paper
• Relationship between Exercise Test Parameters, Device-Delivered Electric Shock and Adverse Clinical Events in Patients with an Implantable Cardioverter Defibrillator for Primary Prevention

  2023cites this paper
• Long-Term Results of the First Clinical Application of Stereotactic Radioablation Using a Linear Electron Accelerator for the Treatment of Ventricular Tachycardia

  2023cites this paper
• Prognostic Value of Different Thresholds for Myocardial Scar Quantification on Cardiac MRI Late Gadolinium Enhancement Images in Patients Receiving Implantable Cardioverter Defibrillators.

  2023cites this paper
• The role of trigger factors in the occurrence of appropriate ICD shocks and their clinical and prognostic implications

  2023cites this paper
• Contemporary management of ventricular arrhythmias in heart failure.

  2023cites this paper
• Recurrences of ventricular tachycardia after stereotactic arrhythmia radioablation arise outside the treated volume: analysis of the Swiss cohort

  2023cites this paper
• Interference of Atrial Fibrillation with Implantable Cardioverter Defibrillator Therapy in Patients with Heart Failure and Reduced Ejection Fraction

  2023cites this paper
• Latest Updates in Heart Failure Imaging.

  2023cites this paper
• Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure

  2022cites this paper
• 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.

  2022cites this paper
• Clinical profile and outcomes of young patients treated with implantable cardioverter defibrillators at a South African tertiary hospital: a review of two decades of implantable cardioverter defibrillator implantation and follow up.

  2022cites this paper
• Catheter ablation of ventricular tachycardia associated with structural heart disease: Current status and perspectives.

  2022cites this paper
• Impact of early ventricular tachycardia ablation in patients with an implantable cardioverter defibrillator: An updated systematic review and meta-analysis of randomized control trials.

  2022cites this paper
• Combination of High-Density and Coherent Mapping for Ablation of Ventricular Arrhythmia in Patients with Structural Heart Disease

  2022cites this paper
• Cardiac 123I-mIBG Imaging in Heart Failure

  2022cites this paper
• Selection and outcome of implantable cardioverter‐defibrillator patients with and without cardiac resynchronization therapy: Comparison of 4384 patients from the German Device Registry to randomized controlled trials

  2022cites this paper
• Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial

  2022cites this paper
• Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.

  2022cites this paper
• Cardiac Magnetic Resonance for Ventricular Tachycardia Ablation and Risk Stratification

  2022cites this paper
• Methodological limitations of psychosocial interventions in Methodological limitations of psychosocial interventions in patients with an implantable cardioverter-defibrillator (ICD) A patients with an implantable cardioverter-defibrillator (ICD) A systematic review. systematic review.

  2022cites this paper
• Outcome of ventricular tachycardia catheter ablation in ischemic heart disease patients using a high-density mapping substrate-based approach: A prospective cohort study.

  2022cites this paper
• Primary Prevention Implantable Cardioverter-Defibrillators in Ischemic Cardiomyopathy

  2022cites this paper
• Safety and efficacy of catheter ablation for ventricular tachycardia in elderly patients with structural heart disease: a systematic review and meta-analysis

  2021cites this paper
• A simplified wall-based model for regional innervation/perfusion mismatch assessed by cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT to predict arrhythmic events in ischaemic heart failure

  2021cites this paper
• Association of Night-Time Heart Rate With Ventricular Tachyarrhythmias, Appropriate and Inappropriate Implantable Cardioverter-Defibrillator Shocks

  2021cites this paper
• Epicardial ablation of ventricular tachycardia in patients with structural heart disease: a single-centre experience over 12 years.

  2021cites this paper
• Delivering an efficient and effective support group for patients with implantable cardioverter-defibrillators (ICDs): patient perspectives of key concerns and predictors of inclination to attend

  2021cites this paper
• Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor?

  2021cites this paper
• JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias

  2021cites this paper
• JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias.

  2021cites this paper
• Survival After Implantable Cardioverter-Defibrillator Shocks.

  2021cites this paper
• A new biomarker that predicts ventricular arrhythmia in patients with ischemic dilated cardiomyopathy: Galectin-3.

  2021cites this paper
• Positron Emission Tomography Imaging of Regional Versus Global Myocardial Sympathetic Activity to Improve Risk Stratification in Patients With Ischemic Cardiomyopathy

  2021cites this paper
• Right Ventricular Function at Cardiac MRI Predicts Cardiovascular Events in Patients with an Implantable Cardioverter-Defibrillator.

  2021cites this paper
• 123I-mIBG in the Risk Stratification of Sudden Cardiac Death in Chronic Heart Failure

  2021cites this paper
• Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention.

  2021cites this paper
• Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area

  2021cites this paper
• The efficacy of catheter ablation versus ICD for prevention of ventricular tachycardia in patients with ischemic heart disease: a systematic review and meta-analysis

  2021cites this paper
• Risk stratification for sudden cardiac death in patients with heart failure

  2021cites this paper
• A standardised pathway increases clinicians' confidence and ability to manage implantable cardioverter defibrillator shocks.

  2021cites this paper
• VT ablation in geriatric patients with structural heart disease: Should there still be an age limit?

  2021cites this paper
• Extent of peri-infarct scar on late gadolinium enhancement cardiac magnetic resonance imaging and outcome in patients with ischemic cardiomyopathy.

  2021cites this paper
• Real-world evaluation of followup strategies after ICD therapies in patients with VT (REFINE-VT).

  2021cites this paper
• Impact of High-Dose Irradiation on Human iPSC-Derived Cardiomyocytes Using Multi-Electrode Arrays: Implications for the Antiarrhythmic Effects of Cardiac Radioablation

  2021cites this paper
• [History of development of ventricular arrhythmias diagnostics].

  2021cites this paper
• Opportunities and perspectives of stereotactic radiosurgery for non-invasive arrhythmology interventions

  2021cites this paper
• Clinical Arrhythmias

  2021cites this paper
• Возможности и перспективы применения стереотаксической радиохирургии для проведения неинвазивных вмешательств в аритмологии

  2021cites this paper
• Prediction of cardiac events with non‐contrast magnetic resonance feature tracking in patients with ischaemic cardiomyopathy

  2021cites this paper
• Sex and Race Disparities in Hypertrophic Cardiomyopathy: Unequal Implantable Cardioverter-Defibrillator Use During Hospitalization.

  2021cites this paper
• Severe chronic kidney disease is associated with poor survival after initial CRT‐defibrillator tachyarrhythmia therapy

  2020cites this paper
• Management of Cardiac Arrhythmias

  2020influential citation
• Living at the boundary between life and death: A qualitative study of how patients' lives are impacted by the implantable cardioverter defibrillator.

  2020cites this paper
• Electrophysiologic mapping and cardiac ablation therapy for prevention of ventricular tachycardia

  2020cites this paper
• Ventricular Tachycardia: Catheter Ablation

  2020cites this paper
• Factors associated with recurrent postinfarction ventricular tachycardia following ablation: a meta-analysis.

  2020cites this paper
• Progression of Infarct-mediated Arrhythmogenesis in a Rodent Model of Heart Failure.

  2020cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

  2020cites this paper
• Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review

  2020cites this paper
• Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials

  2020cites this paper
• Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease.

  2020cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population

  2020cites this paper
• High mean entropy calculated from cardiac MRI texture analysis is associated with antitachycardia pacing failure

  2020cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population

  2020cites this paper
• Optimal Timing of VT Ablation for Patients with ICD Therapies

  2020cites this paper
• Tissue Doppler-Derived Left Ventricular Systolic Velocity Is Associated with Lethal Arrhythmias in Cardiac Device Recipients Irrespective of Left Ventricular Ejection Fraction.

  2020cites this paper
• Sudden death prevention post-myocardial infarction and after VEST.

  2020cites this paper
• Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients

  2020cites this paper
• Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT)

  2020cites this paper
• Heart Failure as a Consequence of Ischemic Heart Disease

  2020cites this paper
• ICD implantation for secondary prevention in patients with ventricular arrhythmia in the setting of acute cardiac ischemia and a history of myocardial infarction

  2020cites this paper
• Recommendations for driving after implantable cardioverter defibrillator implantation and the use of a wearable cardioverter defibrillator

  2020cites this paper
• Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care

  2020cites this paper
• Ventricular tachycardia ablation in structural heart disease: Impact of ablation strategy and non-inducibility as an end-point on long term outcome.

  2019cites this paper
• Risk Stratification Beyond Left Ventricular Ejection Fraction: Role of Cardiovascular Magnetic Resonance

  2019cites this paper